Over the last 7 days, the Australian market has risen 1.1%, and over the past 12 months, it is up 11%, with earnings forecasted to grow by 13% annually. In this favorable environment, identifying undervalued stocks can present significant opportunities for investors looking to capitalize on potential growth. Top 10 Undervalued Stocks Based On Cash Flows In Australia Name Current Price Fair Value (Est) Discount (Est) Regal Partners (ASX:RPL) A$3.39 A$6.77 49.9% Hansen Technologies (ASX:HSN) A$4.21 A$8.20 48.7% IPH (ASX:IPH) A$6.18 A$11.54 46.4% Ansell (ASX:ANN) A$29.55 A$56.92 48.1% Shine Justice (ASX:SHJ) A$0.71 A$1.34 47% HMC Capital (ASX:HMC) A$8.31 A$15.47 46.3% Millennium Services Group (ASX:MIL) A$1.145 A$2.24 48.9% Little Green Pharma (ASX:LGP) A$0.091 A$0.17 46.3% Airtasker (ASX:ART) A$0.265 A$0.52 49.4% Superloop (ASX:SLC) A$1.71 A$3.31 48.4% Click here to see the full list of 43 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. HMC Capital Overview: HMC Capital Limited, with a market cap of A$3.14 billion, owns and manages real estate-focused funds in Australia through its subsidiaries. Operations: HMC Capital generates revenue primarily from real estate at A$77.60 million, supplemented by private equity at A$3.50 million. Estimated Discount To Fair Value: 46.3% HMC Capital reported earnings of A$66 million and sales of A$81.1 million for the year ended June 30, 2024, showing solid growth from the previous year. Trading at A$8.31, it is significantly undervalued compared to its estimated fair value of A$15.47. Although shareholders faced dilution recently, HMC's revenue is forecast to grow by over 20% annually, outpacing market averages and indicating strong future cash flows despite a modest return on equity forecast of 9.5%. Our expertly prepared growth report on HMC Capital implies its future financial outlook may be stronger than recent results. Take a closer look at HMC Capital's balance sheet health here in our report. ASX:HMC Discounted Cash Flow as at Aug 2024 Infomedia Overview: Infomedia Ltd (ASX:IFM) is a technology company that develops and supplies electronic parts catalogues, service quoting software, and e-commerce solutions for the automotive industry worldwide, with a market cap of A$657.61 million. Operations: Revenue from publishing periodicals amounts to A$140.83 million. Estimated Discount To Fair Value: 25.8% Infomedia Ltd reported full-year sales of A$140.83 million, up from A$129.91 million last year, with net income rising to A$12.68 million from A$9.58 million. Trading at A$1.76, it is significantly undervalued compared to its estimated fair value of A$2.37 and shows strong cash flow potential with earnings expected to grow 28.7% annually over the next three years, outpacing the broader Australian market's growth forecast of 12.8%. Our growth report here indicates Infomedia may be poised for an improving outlook. Delve into the full analysis health report here for a deeper understanding of Infomedia. ASX:IFM Discounted Cash Flow as at Aug 2024 Nanosonics Overview: Nanosonics Limited, with a market cap of A$975.65 million, operates as an infection prevention company globally. Operations: The company's revenue primarily comes from its Healthcare Equipment segment, generating A$170.01 million. Estimated Discount To Fair Value: 37% Nanosonics Limited's recent earnings report showed sales of A$170.01 million and net income of A$12.97 million, down from A$19.88 million last year. Trading at A$3.22, it is significantly undervalued compared to its estimated fair value of A$5.11 and is forecasted to grow earnings by 22.3% annually, which is faster than the Australian market average of 12.8%. However, profit margins have decreased from 12% to 7.6%. In light of our recent growth report, it seems possible that Nanosonics' financial performance will exceed current levels. Get an in-depth perspective on Nanosonics' balance sheet by reading our health report here. ASX:NAN Discounted Cash Flow as at Aug 2024 Where To Now? Click this link to deep-dive into the 43 companies within our Undervalued ASX Stocks Based On Cash Flows screener. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:HMC ASX:IFM and ASX:NAN. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
3 ASX Stocks Trading At Up To 46.3% Below Intrinsic Value
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...